StemoniX Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$37.6M
Lead Investor(s):N/A

Estimated Revenue & Financials

  • StemoniX's estimated annual revenue is currently $5.1M per year.(?)
  • StemoniX's estimated revenue per employee is $155,000
  • StemoniX's total funding is $37.6M.

Employee Data

  • StemoniX has 33 Employees.(?)
  • StemoniX grew their employee count by -20% last year.
  • StemoniX currently has 1 job openings.

Our mission is to accelerate the discovery of new medicines with physiologically-relevant, structured human cells that improve cell-based assay outcomes. We develop and scalably manufacture human induced pluripotent stem (iPS) cell-derived cardiac and neuronal platforms for drug discovery and development. Predictive, accurate, and consistent, our human models enable scientists to quickly and economically conduct research with improved outcomes in a simplified workflow. We also collaborate with drug discovery organizations to test their compounds with our in-house screening capabilities, create new cell-based models, and operationalize their human iPS cells at large scale for high throughput screening. StemoniX microHeart® products in high density plate formats provide researchers with structurally aligned cardiac cells resembling native human heart tissue with accelerated features of cell maturity. StemoniX microBrain® products in high density formats are physiologically relevant with biology, activity, functional maturity that mimic native human brain tissue. Available pre-plated to simplify your workflow, microHeart and microBrain are delivered in ambient conditions and ready for assay use soon after delivery. With leading-edge iPSC technologies, we are helping global institutions bring the most promising medicines to patients. Contact us at to discuss how StemoniX products and services can accelerate your discoveries.